104
Participants
Start Date
December 31, 2013
Primary Completion Date
December 31, 2017
Study Completion Date
April 30, 2018
HS-410
Vaccine derived from irradiated cancer cells genetically engineered to continually secrete gp96
Placebo
Injection containing sterile solution but no cells
BCG
Vaccine derived from a live bacterium
Montefiore Medical Center, The Bronx
Thomas Jefferson University, Philadelphia
Johns Hopkins University, Baltimore
Urology of Virginia, Virginia Beach
University of North Carolina Chapel Hill, Chapel Hill
Carolina Urologic Research Center, Myrtle Beach
First Urology, Jeffersonville
Horizon Oncology Research, Lafayette
University of Minnesota, Minneapolis
University of Chicago, Chicago
Washington University School of Medicine, St Louis
University of Kansas Cancer Center, Westwood
Urology of North Texas, Dallas
MD Anderson Cancer Center, Houston
Urology Center of Colorado, Denver
University of California at Los Angeles, Los Angeles
Skyline Urology, Torrance
Skyline Urology, Sherman Oaks
University of Massachusetts, Worcester
Lead Sponsor
Heat Biologics
INDUSTRY